Amplitude Surgical SAS (AMPLI) — Capital Reinvestment Ratio

Latest as of December 2024: 2.66x

Amplitude Surgical SAS (AMPLI) has a Capital Reinvestment Ratio of 2.66x as of December 2024, meaning it reinvests 3% of its operating cash flow (€2.77 Million) in capital expenditures (€7.39 Million). Check Amplitude Surgical SAS tangible net worth ratio to evaluate the tangible quality of the company's equity base.

Capital Reinvestment Ratio

2.66x
Capex / Operating Cash Flow

Operating Cash Flow

€2.77 Million
EUR

Capital Expenditures

€7.39 Million
EUR

Data as of

Dec 2024
Most recent filing

Amplitude Surgical SAS Capital Reinvestment Ratio (2013–2024)

This chart tracks Amplitude Surgical SAS's Capital Reinvestment Ratio across 10 annual periods. For the full cash flow conversion analysis, see Amplitude Surgical SAS (AMPLI) cash conversion ratio.

Annual Capital Reinvestment Ratio for Amplitude Surgical SAS (2013–2024)

Year-by-year Capital Reinvestment Ratio for Amplitude Surgical SAS from 2013 to 2024. See AMPLI free cash flow to operating cash ratio to measure how efficiently the company converts operating cash flow to free cash.

Year Reinvestment Ratio Operating CF (EUR) Capital Expenditures YoY Change
2024 2.57x €4.04 Million €10.38 Million ▲ +7.2%
2023 2.40x €8.10 Million €19.39 Million ▲ +57.5%
2022 1.52x €7.98 Million €12.14 Million ▼ -62.3%
2021 4.03x €2.34 Million €9.45 Million ▲ +412.0%
2020 0.79x €12.38 Million €9.75 Million ▼ -22.8%
2019 1.02x €8.24 Million €8.40 Million ▲ +21.1%
2018 0.84x €8.98 Million €7.55 Million ▼ -88.6%
2017 7.36x €2.68 Million €19.71 Million ▲ +10.8%
2016 6.64x €1.99 Million €13.20 Million ▼ -85.7%
2013 46.56x €197.00K €9.17 Million
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow